요약
Health 05월 07일
Hantavirus outbreak on MV Hondius cruise ship kills three and strands vessel off Cape Verde
The MV Hondius cruise ship that departed Ushuaia for Cabo Verde has experienced a confirmed hantavirus outbreak resulting in three passenger deaths. Two additional individuals showing symptoms remain aboard while authorities work to arrange their evacuation. The vessel carrying 149 people including 14 Spaniards is currently anchored off the coast of Praia in Cape Verde after local officials denied docking permission over outbreak concerns. The World Health Organization is coordinating response measures and has commended the swift actions taken so far. Spain's government working with the WHO has approved docking in the Canary Islands within three to four days. Three passengers including a gravely ill doctor will be airlifted for immediate treatment upon arrival. None of the 38 Filipino crew members have fallen ill according to the Philippines Department of Health. A Swiss man who disembarked earlier at Saint Helena tested positive for Andes hantavirus and is isolated in a Zurich hospital. The ship is now heading to Tenerife where passenger evacuations are scheduled to begin on May 11 with foreign nationals to be repatriated and the Spanish passengers quarantined in Madrid after a formal WHO request. The vessel departed Ushuaia on April 1 and remains in quarantine as investigations proceed.
- Three passengers die from hantavirus on MV Hondius cruise from Ushuaia
- MV Hondius cruise ship stranded off Cape Verde over possible hantavirus outbreak
- Spain agrees to dock MV Hondius hantavirus cruise ship in Canary Islands
- MV Hondius 한타바이러스 발병에도 필리핀 선원들은 이상 없어; 카보베르데 인근 해상 격리 중
- Swiss passenger confirmed with Andes hantavirus after MV Hondius stop at Saint Helena
- Spain to host hantavirus cruise ship in Tenerife after WHO request
- Hantavirus outbreak on MV Hondius leaves three dead amid ongoing evacuations
- MV Hondius cruise ship with hantavirus heads to Tenerife for evacuations
New technologies allow researchers to examine nanoscale functions of the human immune system
New technologies are enabling researchers to examine the nanoscale operations of the human immune system in unprecedented detail. Immunologist Daniel Davis presented these developments at WIRED Health emphasizing how such insights may lead to improved strategies for treating conditions including cancer. The advances provide a deeper understanding of immune responses at the molecular level which could reshape approaches to disease management and therapy development in the coming years. By visualizing cellular interactions more precisely scientists gain valuable data on how the immune system functions under various conditions.
Former New York City Mayor Rudy Giuliani hospitalized in Florida in critical but stable condition
Former New York City Mayor Rudy Giuliani aged 81 has been admitted to a hospital in Florida where his condition is described as critical but stable. A spokesman issued a statement confirming the hospitalization on Sunday while former President Donald Trump shared a message of support via Truth Social. No specific cause for the admission has been released to the public at this time. The event has drawn attention from political circles and media outlets monitoring the health of high-profile individuals.
Technology-assisted hydration program shows limited impact on kidney stone recurrence in U.S. trial
A two-year clinical trial conducted in the United States involving 1658 adolescents and adults who had previously experienced kidney stones tested a technology-assisted hydration program. The intervention modestly increased urine output among participants yet it did not lead to a significant reduction in symptomatic stone recurrences when compared with standard care. Researchers observed the hydration support through digital means but concluded that the approach offered only incremental physiological changes without translating into meaningful clinical benefits for recurrence prevention. The findings suggest that further refinements may be needed to enhance the effectiveness of such programs in real-world settings.
Stellenbosch University researchers identify rare flavoalkaloids in cannabis leaves for first time
Researchers at Stellenbosch University have reported the first evidence of rare phenolic compounds known as flavoalkaloids present in cannabis leaves. The team profiled dozens of plant chemicals across three commercially grown strains to make the discovery. This finding expands the known chemical profile of cannabis and may open new avenues for studying the plant's bioactive components. The identification was achieved through detailed analysis of leaf samples from established cultivation sources providing a foundation for future research into these previously undetected compounds.